Troluce Capital Advisors »

BioMarin Pharmaceutical shares owned by Troluce Capital Advisors

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Troluce Capital Advisors from 13F filings

Historical chart of Troluce Capital Advisors investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Troluce Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Troluce Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.0M 100k 70.29
2024-06-30 $5.9M 72k 82.33

More positions owned by Troluce Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Endeavor Group Hldgs Cl A Com Put Option (EDR)
Tko Group Holdings Cl A (TKO)
Summit Matls Cl A Put Option (SUM)
Select Sector Spdr Tr Indl Put Option (XLI)
Smurfit Westrock SHS
Live Nation Entertainment Put Option (LYV)
Western Digital Call Option (WDC)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Flutter Entmt SHS Call Option (FLUT)
Vistra Energy Put Option (VST)
Siriusxm Holdings Common Stock Call Option
Select Sector Spdr Tr Sbi Materials Put Option (XLB)
Roivant Sciences SHS (ROIV)
Capri Holdings SHS (CPRI)

View all positions for Troluce Capital Advisors

Top funds holding BioMarin Pharmaceutical

BlackRock
BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
Capital Research Global Investors
Viking Global Investors
State Street Corporation
Elliott Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding BioMarin Pharmaceutical